The likelihood of total knee arthroplasty following arthroscopic surgery for osteoarthritis: a systematic review by Winter, Amelia R. et al.
The likelihood of total knee arthroplasty
following arthroscopic surgery for
osteoarthritis: a systematic review
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Winter, Amelia R., Jamie E. Collins, and Jeffrey N. Katz. 2017. “The
likelihood of total knee arthroplasty following arthroscopic surgery
for osteoarthritis: a systematic review.” BMC Musculoskeletal
Disorders 18 (1): 408. doi:10.1186/s12891-017-1765-0. http://
dx.doi.org/10.1186/s12891-017-1765-0.
Published Version doi:10.1186/s12891-017-1765-0
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34492421
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
RESEARCH ARTICLE Open Access
The likelihood of total knee arthroplasty
following arthroscopic surgery for
osteoarthritis: a systematic review
Amelia R. Winter1, Jamie E. Collins1,3 and Jeffrey N. Katz1,2,3,4*
Abstract
Background: Arthroscopic surgery is a common treatment for knee osteoarthritis (OA), particularly for symptomatic
meniscal tear. Many patients with knee OA who have arthroscopies go on to have total knee arthroplasty (TKA). Several
individual studies have investigated the interval between knee arthroscopy and TKA. Our objective was to summarize
published literature on the risk of TKA following knee arthroscopy, the duration between arthroscopy and TKA, and risk
factors for TKA following knee arthroscopy.
Methods: We searched PubMed, Embase, and Web of Science for English language manuscripts reporting TKA following
arthroscopy for knee OA. We identified 511 manuscripts, of which 20 met the inclusion criteria and were used for analysis.
We compared the cumulative incidence of TKA following arthroscopy in each study arm, stratifying by type of
data source (registry vs. clinical), and whether the study was limited to older patients (≥ 50) or those with more
severe radiographic OA. We estimated cumulative incidence of TKA following arthroscopy by dividing the number of TKAs
among persons who underwent arthroscopy by the number of persons who underwent arthroscopy. Annual incidence
was calculated by dividing cumulative incidence by the mean years of follow-up.
Results: Overall, the annual incidence of TKA after arthroscopic surgery for OA was 2.62% (95% CI 1.73–3.51%).
We calculated the annual incidence of TKA following arthroscopy in four separate groups defined by data source (registry
vs. clinical cohort) and whether the sample was selected for disease progression (either age or OA severity). In unselected
registry studies the annual TKA incidence was 1.99% (95% CI 1.03–2.96%), compared to 3.89% (95% CI 0.69–7.09%) in
registry studies of older patients. In unselected clinical cohorts the annual incidence was 2.02% (95% CI 0.67–3.36%), while
in clinical cohorts with more severe OA the annual incidence was 4.13% (95% CI 1.81–6.44%). The mean and median
duration between arthroscopy and TKA (years) were 3.4 and 2.0 years.
Conclusions: Clinicians and patients considering knee arthroscopy should discuss the likelihood of subsequent TKA as they
weigh risks and benefits of surgery. Patients who are older or have more severe OA are at particularly high risk of TKA.
Keywords: Osteoarthritis, Total knee arthroplasty, Arthroscopic partial meniscectomy, Arthroscopy
Background
Osteoarthritis (OA) is a debilitating disease, affecting over
40 million people in the United States [1, 2]. Of those
affected, approximately 14 million have symptomatic knee
OA [3], which presents with pain, loss of knee joint func-
tion, and loss of valued activities. In addition, about 90% of
those with symptomatic knee OA have meniscal tears
(MT) documented on magnetic resonance imaging (MRI)
[4]. However, no available treatments modify the structural
progression associated with OA. Symptoms are generally
managed with conservative therapies (e.g., nonsteroidal
anti-inflammatory drugs (NSAIDs), exercise, physical ther-
apy). Patients and their physicians often turn to surgical
treatments to address progressive pain and disability, in-
cluding arthroscopy and total knee arthroplasty (TKA).
Over 600,000 arthroscopic partial meniscectomies
(APM) are performed each year in the United States [5],
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most commonly on persons over 45 with MT [5, 6]. The
benefit of arthroscopic surgery in patients with OA is
uncertain and debated. Moseley et al. showed that sham
surgery and arthroscopic surgery for OA had similar
pain relief and functional improvement up to 2 years
post-surgery [7]. Kirkley and colleagues showed that
arthroscopy and a conservative exercise regimen had
similar symptomatic and functional outcomes in persons
with knee OA [8]. With respect to MT in the setting of
OA, several trials demonstrated that surgery was not
superior to nonoperative therapy or sham surgery in
intention to treat analyses [9–12], while one trial showed
a benefit for surgery [13]. Thus, arthroscopic surgery is
felt to be ineffective for OA per se, while the effective-
ness of APM in persons with MT and concomitant OA
is debated [14].
Often, people who undergo arthroscopic surgery for
osteoarthritis progress to TKA. While some studies
suggest that up to 20% of patients undergo TKA within
one year of arthroscopy [15], other studies have shown
TKA rates under 5% [16]. The various studies of the rate
of TKA after arthroscopy have not been summarized, to
our knowledge. Such a summary of the risk of TKA
following arthroscopy and the duration between arthros-
copy and TKA would be helpful for clinicians to better ad-
vise patients and their families on appropriate treatments
plans. Surgery is expensive – about $2 billion dollars are
spent on arthroscopy for OA [17] and over $10 billion
dollars are spent on TKAs each year [18]. Therefore, im-
proved knowledge of the risk for TKA following arthros-
copy could also lead to better resource allocation for OA.
We performed a systematic review of the literature on
the risk of TKA following arthroscopic surgeries for OA.
We expected to see older patients and those with more
severe OA, progress to TKA more quickly after surgery.
Methods
Definition of search terms
A search by title was performed on PubMed, Embase, and
Web of Science using the major search terms: osteoarthritis,
knee; arthroscopy; and arthroplasty (see Additional file 1:
Table S1 for search strings). The search was performed in
September 2016 and titles were downloaded to EndNote.
One reviewer (ARW) manually screened titles for inclusion
and exclusion criteria, arriving at a final list of titles. For
these titles, the reviewer assessed abstracts for inclusion and
exclusion criteria. For each abstract that was not excluded,
the full manuscript was read to determine ultimate inclusion
in the final analysis. A second reviewer confirmed that the
final selected manuscripts met inclusion criteria.
Inclusion and exclusion criteria
We sought studies investigating the rate of arthroplasty
after arthroscopic knee surgery for osteoarthritis. Therefore,
inclusion criteria included: English language and human
studies on the risk of TKA occurring following arthroscopic
procedures for knee OA. Manuscripts were excluded if they
were duplicates, written in a language other than English,
or conducted on animals. Studies were also excluded if they
examined only arthroscopy or arthroplasty rather than the
risk of arthroplasty following arthroscopy. Case studies and
studies with cohorts of mean age < 40 were also excluded.
Confusion regarding inclusion of a study was resolved by
consulting with the senior author (JNK).
Data abstraction
From the manuscripts, the reviewer (ARW) extracted
the following information (if available): author, year, title,
administrative data (e.g., clinical cohort or registry),
country, patient selection criteria (e.g. age, KL grade),
subgroup information, size of analysis group, mean age,
analysis method (e.g., cumulative incidence), duration
between arthroscopy and TKA, duration of follow-up,
percentage of TKA, and study arm population description.
Another reviewer abstracted key data (e.g., country,
administrative data, patient selection criteria, follow-up
years, analysis group, and total TKA numbers) from the
included studies. The results from both abstractions were
compared and found to be the same.
Categorization of studies
We examined the cumulative incidence of TKA following
knee arthroscopy in specific patient subgroups. These
included source of data (administrative data registries vs.
clinical cohort studies), OA severity, older age (e.g., selec-
tion for population ≥ 50), and country. Some of the clin-
ical cohort studies recruited patients with advanced OA,
(i.e., KL grade ≥ 3 or Outerbridge score ≥ 2). We defined
these study arms as “Clinical Cohort – More Severe OA.”
One study (Lyu et al., 2015) was included among the
“Clinical Cohort – More Severe OA” group as its patient
population was over 75% KL grade 3 or higher. Some
registry studies were restricted to subjects with age greater
than 50. We referred to these as “Registry – Older Age.”
We created a final categorization combining the source of
data and selection criteria: “Registry – Unselected,” “Regis-
try – Older Age,” “Clinical Cohort – Unselected,” and
“Clinical Cohort – More Severe OA.” For countries, we
combined England and Scotland as “U.K.”
Quality assessment
We used the Quality Assessment Tool for Observational
Cohort and Cross-Sectional Studies developed by investiga-
tors at the National Heartt, Lung and Blood Intitute
(NHLBI), based upon work done at the Agency for Health
Care Research and Quality. (https://www.nhlbi.nih.gov/
health-pro/guidelines/in-develop/cardiovascular-risk-reduct
ion/tools/cohort) [19]. This measure includes 14 items
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relevant to the quality of cohort studies, with emphasis on
explicit specification of sample characteristics, exposures,
primary outcomes and potential confounders. Two authors
performed the assessment independently and resolved any
disagreements.
Analyses
For studies that did not provide cumulative incidence
data, we calculated cumulative incidence using the number
of TKAs divided by the number of arthroscopic patients
included for follow-up analysis. We first examined the asso-
ciation between the type of data source – registry vs. cohort
– and TKA rates. Then, we evaluated the association
between study category (“Registry – Unselected,” “Registry
– Older Age,” “Clinical Cohort – Unselected,” and “Clinical
Cohort – More Severe OA,” as described above) and an-
nual incidence. In secondary analyses, we evaluated the dif-
ference between TKA annual incidence in unselected study
arms (clinical and registry) vs. selected study arms, regard-
less of registry status. We compared studies in which mean
age of the study was >65 to those with mean age < 65.
We divided cumulative incidence of TKA by mean
years of follow-up to obtain an annual incidence estimate.
We computed exact confidence intervals for each yearly
incidence value. We used a logistic random-effects model
to create an overall combined estimate of annual TKA in-
cidence across all studies and to evaluate the effect of
study-level characteristics on TKA incidence. This ap-
proach allows for studies with zero cells (i.e., 0% incidence
rate) without requiring an ad-hoc adjustment [20]. All
analyses were conducted using SAS 9.4 (SAS Institute,
Cary NC).
Results
Five hundred eleven unique articles were found using
our search terms and three search engines. After screen-
ing the titles, we were left with 328 articles whose ab-
stracts were subsequently reviewed. Over half of the
articles excluded did not have arthroscopic surgery be-
fore TKA (36%) or did not report TKA (24%). Fifty-five
articles underwent full article review. Thirty-five of the
manuscripts were excluded from our analysis: 11 were
not written in English, 2 did not report on arthroscopic
procedures before TKA, 3 did not report on TKA, and
19 were excluded for other reasons, such as mixed co-
hort (e.g., OA and post-traumatic arthritis), secondary
sources, or insufficient data on methodology.
These exclusions left 20 articles for the analysis (Fig. 1).
The 20 studies contained 28 unique study arms (Table 1).
The 28 study arms were reported from eight countries.
The U.S.A. accounted for 15 of the 28, the U.K. for 5,
Canada for 3, and Australia, Belgium, Italy, South Korea,
and Taiwan for one each. The quality assessment docu-
mented relatively little variability in quality. Essentially
all the studies stated the research question clearly, speci-
fied the population and defined the exposure and outcome
explicitly. Only one study provided a power calculation.
Rates of participation among eligible subject and rates of
follow up were generally high, particularly for administra-
tive data studies in which participation and follow-up rates
are typically 100%. Some of the quality items did not apply
to the studies we reviewed because all subjects in our
studies were ‘exposed’ (had arthroscopy).
Overall, the yearly incidence for TKA after arthroscopic
surgery for OA was 2.62% (95% CI 1.73–3.51%). The mean
and median duration between arthroscopy and TKA (years)
were 3.4 and 2.0 years. From our 28 study arms, we identi-
fied sixteen clinical cohorts and twelve registry samples.
The clinical cohort studies had a yearly TKA incidence of
2.94% (95% CI 1.54–4.33%), compared to the registry stud-
ies, which had an incidence of 2.36% (95% CI 1.26–3.46%)
(p = 0.5048). We examined separately the risk of TKA
in four distinct subgroups: “Registry – Unselected,”
“Registry – Older Age,” “Clinical Cohort – Unselected,”
and “Clinical Cohort – More Severe OA.” The four
subgroups are shown in Fig. 2.
Registry - unselected
A total of nine study arms were unselected registries,
with a median of 6972 (range 842–159,975) patients per
study arm (Table 1). Of these, the average yearly inci-
dence for TKA was 1.99% (95% CI 1.03–2.96%) (Fig. 2).
Registry – Older age
A total of three study arms were registries using data
from patients ≥50 years old, with a median of 6212
(range 3033–40,804) patients per study arm (Table 1).
Of these studies, the average yearly incidence for TKA
was 3.89% (95% CI 0.69–7.09%) (Fig. 2).
Clinical cohort – Unselected
A total of seven study arms were unselected clinical co-
horts, with a median of 42 (range 8–183) patients per study
arm (Table 1). Of these studies, the average yearly incidence
for TKA was 2.02% (95% CI 0.67–3.36%) (Fig. 2).
Clinical cohort – More severe OA
A total of nine study arms were clinical cohorts selecting
for patients with more severe OA on the basis of KL
grade or Outerbridge score, with a median of 69 (range
68–844) patients per study arm (Table 1). Of these studies,
the average yearly incidence for TKA was 4.13% (95% CI
1.81–6.44%) (Fig. 2).
Comparisons: Age and OA severity
We evaluated the association between TKA incidence
and study inclusion criteria using a logistic random-
effects model. We found that selected studies - those
Winter et al. BMC Musculoskeletal Disorders  (2017) 18:408 Page 3 of 8
that selected subjects based on OA severity or age -
were twice as likely to undergo TKA compared to unse-
lected studies (4.05% compared to 2.00%; p = 0.0243).
Studies of subject with a mean age of less than 65 had a
yearly incidence of 1.87% (95% CI 1.16–2.57%) com-
pared to 5.13% (95% CI 2.61–7.64%) for those with mean
age over 65. This difference was statistically significant
(p = 0.0027).
Discussion
We evaluated published literature on the risk of TKA in
patients undergoing knee arthroscopy. A concern about
the use of arthroscopic surgery in the setting of OA and
OA with meniscal tear is that APM may lead to more
rapid OA progression, leading to TKA more quickly [1, 15].
We found that on average the risk of TKA following arth-
roscopy was about 2% per year and that the mean and
medican duration between arthroscopy and TKA were 3.4
and 2.0 years respectively. Further, study arms of patients
who were older or had more advanced radiographic OA at
the time of arthroscopy had two-fold higher risk of TKA
than unselected study arms. These findings should be
viewed in the context of other documented risk factors for
OA progression including older age, female gender, varus
and valgus malalignment and bone marrow lesions, among
others [21].
Our findings are consistent with studies showing that
OA severity and age are associated with TKA [22–32].
Indeed, surgeons may be reluctant to offer TKA to
younger patients, because they face a risk of a revision
TKA. Advanced OA is a typical indication for TKA, as
embodied in guidelines such as those of the American
Academy of Orthopaedic Surgeons [33].
Our study must be interpreted in the context of sev-
eral limitations. The clinical cohort data provided insight
into the KL grades and Outerbridge scores of patients
511 titles met search criteria
PubMed 311
Embase 120
Web of Science 80
328 abstracts screened
Reason for exclusion:
-Duplicate: 104
-Animal Study: 2
-Not Knee Study: 3
-No surgery for OA/MT: 71
-No arthroscopic surgery pre-TKA: 2
-Other: 1
55 articles reviewed
Reason for exclusion:
-No abstract: 39
-Animal Study: 2
-Not Knee Study: 3
-No surgery for OA/MT: 31
-No arthroscopic surgery pre-TKA: 98
-No TKA: 65
-Case study: 2
-Other: 33
20 articles included in the
systematic review
Reason for exclusion:
-Not English: 11
-No arthroscopic surgery pre-TKA: 2
-No TKA: 3
-Other: 19
Fig. 1 Search and selection process
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whereas registry data included age but no information
on OA severity nor on the details of surgery. The com-
ponent studies did not perform analyses of subgroups
that might be prognostically distinct, such as athletes
and non-athletes, or males and females. Similarly, over
half of the countries contributed just one cohort. This
precludes meaningful analysis of between-country differ-
ences. While we performed replicate abstractions of all
papers we did not repeat the screening of titles and ab-
stracts in duplicate, creating the theoretical risk of our
missing an eligible paper. As reflected in our quality as-
sessment, the studies consistently defined the exposure
and outcome explicitly. Since most of the larger studies
used administrative data, the follow-up rates were gener-
ally 100%. We note as well that some patients with a
medical ‘need’ for TKA (symptomatic, advanced OA)
may not have received the procedure because of their
own preferences or the practice styles of their physicians
or still other reasons. When TKA is used as a health
outcome, the role of these patient, physician and health
system factors may attenuate the risk associated with
specific variables such as prior arthroscopic surgery.
To the best of our knowledge, this is the first system-
atic review to analyze the yearly TKA incidence rate for
those having undergone arthroscopic surgery for knee
OA. Quality assessment of the studies generally reflected
consistent specification of exposures, outcomes, and study
samples and high rates of participation and follow-up. The
findings suggest that OA patients undergoing arthroscopy
and their physicians should anticipate an annual rate of
TKA on the order of 2%, with higher rates among older
patients and those with more advanced OA. These
findings should be shared with patients when clinicians
discuss the advantages and drawbacks of arthroscopy.
Conclusion
Clinicians and patients considering knee arthroscopy should
discuss the likelihood of subsequent TKA as they weigh
risks and benefits of surgery. Patients who are older or have
more severe OA are at particularly high risk of TKA.
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